Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Operating Grant - PA: Genetics (Bridge Funding: Research Priorities)

University of Calgary

$100,000.00

Uncovering complex genetic mechanisms of disease

FY 2022-23

Summary
Genetic diseases result from alterations of genetic material that lead to functional impact on genes. Despite the recent advancements in genomics that have facilitated sequencing of individual human genomes, the genetic cause is difficult to identify in the majority of individuals with presumed genetic disease. This persisting problem may largely be due to more complex genetic scenarios that involve genetic variation beyond simple coding variants, that current genetic tests are not efficiently addressing. How do we increase the ability of genetic testing to reliably detect and interpret complex molecular causes? We reasoned that patients with well-defined clinical features and highly suspected clinical diagnoses, yet with no or partial genetic diagnosis, will help us better understand the spectrum of these intricate variants by narrowing the genetic focus. For example, ataxia-telangiectasia (AT) is a disease known to be caused by alterations of a single gene, ATM. Patients with clinical diagnosis of AT for whom conventional genetic/genomic tests failed to identify disruptive variants in the ATM, hold a clue to more complex mechanisms of gene disruption. Our pilot genome sequencing study in patients with well-defined clinical features, including AT and similar diseases, who remained without genetic diagnosis revealed a spectrum of complex molecular causes. In one of the patients, the discovery of new genetic change has opened doors for personal therapy development. Here, we propose to expand our patient cohort and decipher complex genetic causes of disease in order to facilitate: (1) better understanding of spectrum of mechanisms of gene disruption; (2) development of improved analytical protocols for identification of these challenging variants with a potential to increase overall success of finding genetic cause of a disease; and (3) development of personal therapies.
Program
Operating Grant - PA: Genetics (Bridge Funding: Research Priorities)
Location
Alberta, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database

As published

Id
472590
Name
Tarailo-Graovac Maja
Region
Alberta
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Genetics
Theme2
Biomedical
Prcname2
Genomics: Systems and computational biology
Projecttitle
Uncovering complex genetic mechanisms of disease
Programtype2
Operating Grants
Orgnameinp2
University of Calgary
Cihramount2
$100,000
Cihrequipment2
$0
Programname2
Operating Grant - PA: Genetics (Bridge Funding: Research Priorities)
Keyworddelim
Bioinformatics; Complex Variants; Genome Sequencing; Genomics; Mechanism Of A Disease; Model Organism; Non-Coding Variants; Rare Disease; Structural Variants; Transcriptomics
Abstract
Genetic diseases result from alterations of genetic material that lead to functional impact on genes. Despite the recent advancements in genomics that have facilitated sequencing of individual human genomes, the genetic cause is difficult to identify in the majority of individuals with presumed genetic disease. This persisting problem may largely be due to more complex genetic scenarios that involve genetic variation beyond simple coding variants, that current genetic tests are not efficiently addressing. How do we increase the ability of genetic testing to reliably detect and interpret complex molecular causes? We reasoned that patients with well-defined clinical features and highly suspected clinical diagnoses, yet with no or partial genetic diagnosis, will help us better understand the spectrum of these intricate variants by narrowing the genetic focus. For example, ataxia-telangiectasia (AT) is a disease known to be caused by alterations of a single gene, ATM. Patients with clinical diagnosis of AT for whom conventional genetic/genomic tests failed to identify disruptive variants in the ATM, hold a clue to more complex mechanisms of gene disruption. Our pilot genome sequencing study in patients with well-defined clinical features, including AT and similar diseases, who remained without genetic diagnosis revealed a spectrum of complex molecular causes. In one of the patients, the discovery of new genetic change has opened doors for personal therapy development. Here, we propose to expand our patient cohort and decipher complex genetic causes of disease in order to facilitate: (1) better understanding of spectrum of mechanisms of gene disruption; (2) development of improved analytical protocols for identification of these challenging variants with a potential to increase overall success of finding genetic cause of a disease; and (3) development of personal therapies.
Competitiondate
202209
Approvedterm2
1 yr 0 mth
Pinamesdelim
Tarailo-Graovac, Maja
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $100,000~ $0~
University of Calgary - $100,000 Grant (2022-23) | Canada Spends